Cefonicid (monosodium)
Pharmacokinetic studies of Cefonicid monosodium have shown that high blood concentrations can be achieved rapidly after intravenous and intramuscular injection, and that concomitant use of albendazole prolongs its half-life in the body and reduces the rate of renal excretion[1].
Product Specifications
CAS Number
71420-79-6
UNSPSC
12352005
Target
Endogenous Metabolite
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Others
Assay Protocol
https://www.medchemexpress.com/cefonicid-monosodium.html
Smiles
O=C(O)C(N12)=C(CSC3=NN=NN3CS(=O)(O[Na])=O)CS[C@]2([H])[C@H](NC([C@H](O)C4=CC=CC=C4)=O)C1=O
Molecular Formula
C18H17N6NaO8S3
Molecular Weight
564.55
References & Citations
[1]Pitkin D, et al. Kinetics and renal handling of cefonicid[J]. Clinical Pharmacology & Therapeutics, 1981, 30 (5) : 587-593.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
![cis-4-[[2-(1H-Benzimidazol-6-ylamino)-8-quinazolinyl]oxy]-cyclohexanol](https://cdn.genprice.uk/products/572/8928860491798/imageurl/trc-b197005-1mg.webp)
cis-4-[[2-(1H-Benzimidazol-6-ylamino)-8-quinazolinyl]oxy]-cyclohexanol
Human TNF-α (Tumor Necrosis Factor Alpha) solid ELISPOT Kit
Human TNF-α (Tumor Necrosis Factor Alpha) solid ELISPOT Kit
